BESTWAY Pharmaceutical Co., Ltd.
-
Founded in:
2000-09-28 -
Country:
China -
Address:
No. 39, Jinyang Road, Nanning -
Tax NO.:
914501007188986064 -
Registered Funds:
184.08 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ofloxacin |
This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.
More
This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death. |
82419-36-1 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Isatidis Radix |
|
0 | ||
| Calcium sulfate dihydrate |
|
10101-41-4 | 0 | |
| PHRAGMITIS RHIZOMA |
|
0 | ||
| Rehmannia |
|
0 | ||
| CURCUMAE RADIX |
|
0 | ||
| ANEMARRHENAE RHIZOMA |
|
0 | ||
| ACORI TATARINOWII RHIZOMA |
|
0 | ||
| POGOSTEMONIS HERBA |
|
0 | ||
| Forsythiae Fructus |
|
0 | ||
| Honey |
|
8028-66-8 | 91 | |
| Sucrose |
|
57-50-1 | 73 | |
| Methyl Hydroxyphenidyl |
|
0 | ||
| Ethylparaben |
|
120-47-8 | 1 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| lonicera caprifolium extract |
|
84603-62-3 | 0 | |
| Baical Skullcap Root Extract |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Aluminum hydroxide |
This product has the effects of anti-acid, protecting ulcer surface, and local hemostasis. Its effect is slow and long-lasting, but its efficacy is weak.
More
This product has the effects of anti-acid, protecting ulcer surface, and local hemostasis. Its effect is slow and long-lasting, but its efficacy is weak. |
21645-51-2 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acetylsalicylic acid |
It acetylates the cyclooxygenase of platelets, thereby inhibiting the release reaction of platelets, reducing the adhesion rate of platelets, and preventing thrombosis. It synergizes with dipyridamole to enhance the anti-thrombotic effect and improve microcirculation.
More
It acetylates the cyclooxygenase of platelets, thereby inhibiting the release reaction of platelets, reducing the adhesion rate of platelets, and preventing thrombosis. It synergizes with dipyridamole to enhance the anti-thrombotic effect and improve microcirculation. |
75mg | 50-78-2 | 35 |
| Dipyridamole |
It has a strong dilating effect on coronary blood vessels, significantly increases coronary flow, enhances myocardial oxygen supply, and inhibits platelet aggregation to prevent thrombosis. It synergizes with aspirin to enhance anti-thrombotic effects and improve microcirculation.
More
It has a strong dilating effect on coronary blood vessels, significantly increases coronary flow, enhances myocardial oxygen supply, and inhibits platelet aggregation to prevent thrombosis. It synergizes with aspirin to enhance anti-thrombotic effects and improve microcirculation. |
25mg | 58-32-2 | 36 |